Senior insider sale
Chief Scientific Officer at X4 PHARMACEUTICALS, INC — senior position signals high conviction
$49.0K
76.92K shares
What this filing means
TAVERAS ARTHUR plans to sell 76.92K shares of X4 PHARMACEUTICALS, INC valued at approximately $49.0K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 10/7/2024ACC: 0001973141-24-000488
Officer· Chief Scientific Officer
Since Nov 2020
76.92K
Shares to sell
$49.0K
Approx. market value
76.92K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Stock Award
N/A
10/4/2024
76.92KTotal acquired76.92K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
10/4/2024 | Stock Award N/A | 76.92K | — |
| Total | 76.92K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
76.92K
Market value
$49.0K
10/7/2024
Total
Units
76.92K
Value
$49.0K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
10/7/2024 | 76.92K | $49.0K | NASDAQ | Planned |
| Total | 76.92K | $49.0K | ||